Health spending follows pace of population aging: challenges lying ahead of the largest Western balkan market.
作者信息
Stojkovic Milica, Milovanovic Olivera
机构信息
Faculty of Medical Sciences, University of Kragujevac , Kragujevac , Serbia.
Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac , Kragujevac , Serbia.
出版信息
Front Public Health. 2015 Apr 20;3:58. doi: 10.3389/fpubh.2015.00058. eCollection 2015.
Abstract
摘要
相似文献
1
Health spending follows pace of population aging: challenges lying ahead of the largest Western balkan market.
Front Public Health. 2015 Apr 20;3:58. doi: 10.3389/fpubh.2015.00058. eCollection 2015.
2
Evolution of the Serbian pharmaceutical market alongside socioeconomic transition.
Expert Rev Pharmacoecon Outcomes Res. 2015 Jun;15(3):521-30. doi: 10.1586/14737167.2015.1003044. Epub 2015 Jan 16.
3
Hong Kong domestic health spending: financial years 1989/90 to 2010/11.
Hong Kong Med J. 2013 Dec;19(6 Suppl 7):1-24.
4
Hong Kong's domestic health spending--financial years 1989/90 through 2004/05.
Hong Kong Med J. 2008 Apr;14 Suppl 2:2-23.
5
Hong Kong domestic health spending: financial years 1989/90 to 2011/12.
Hong Kong Med J. 2015 Jun;21(3 Suppl 3):1-24.
6
Hong Kong domestic health spending: financial years 1989/90 to 2005/06.
Hong Kong Med J. 2010 Feb;16 Suppl 2:1-23.
7
Hong Kong domestic health spending: financial years 1989/90 to 2009/10.
Hong Kong Med J. 2013 Apr;19(2 Suppl 3):1-24.
8
The New and Old Europe: East-West Split in Pharmaceutical Spending.
Front Pharmacol. 2016 Feb 9;7:18. doi: 10.3389/fphar.2016.00018. eCollection 2016.
9
Hong Kong domestic health spending: financial years 1989/90 to 2008/09.
Hong Kong Med J. 2012 Aug;18(4 Suppl 4):1-23.
10
Cold War Legacy in Public and Private Health Spending in Europe.
Front Public Health. 2018 Aug 6;6:215. doi: 10.3389/fpubh.2018.00215. eCollection 2018.
引用本文的文献
1
Challenges of Providing Access to Cutting-Edge Cancer Medicines in the Countries of Eastern Europe.
Front Public Health. 2018 Jul 24;6:193. doi: 10.3389/fpubh.2018.00193. eCollection 2018.
2
Do health care workforce, population, and service provision significantly contribute to the total health expenditure? An econometric analysis of Serbia.
Hum Resour Health. 2016 Aug 15;14(1):50. doi: 10.1186/s12960-016-0146-3.
3
Commentary: Patient Cost Sharing and Medical Expenditures for the Elderly.
Front Pharmacol. 2016 Mar 30;7:73. doi: 10.3389/fphar.2016.00073. eCollection 2016.
本文引用的文献
1
Growing Burden of Non-Communicable Diseases in the Emerging Health Markets: The Case of BRICS.
Front Public Health. 2015 Apr 23;3:65. doi: 10.3389/fpubh.2015.00065. eCollection 2015.
2
A comment on the article: Stošić S, Karanović N. Health care economics in Serbia: current problems and changes. Vojnosanit Pregl 2014; 71(11): 1055-1061.
Vojnosanit Pregl. 2015 Feb;72(2):203-5.
3
Evolution of the Serbian pharmaceutical market alongside socioeconomic transition.
Expert Rev Pharmacoecon Outcomes Res. 2015 Jun;15(3):521-30. doi: 10.1586/14737167.2015.1003044. Epub 2015 Jan 16.
4
Economic analysis of social services for the elderly in Serbia: two sides of the same coin.
Eval Program Plann. 2014 Aug;45:9-21. doi: 10.1016/j.evalprogplan.2014.03.004. Epub 2014 Mar 12.
5
Resource allocation strategies in Southeastern European health policy.
Eur J Health Econ. 2013 Apr;14(2):153-9. doi: 10.1007/s10198-012-0439-y.
6
Validation of a patient satisfaction questionnaire in primary health care.
Public Health. 2012 Aug;126(8):710-8. doi: 10.1016/j.puhe.2012.03.008. Epub 2012 Jul 24.
7
Aging in Serbia.
Adv Gerontol. 2009;22(4):553-7.
Zotero 插件